IFP Advisors 13F: Exits DuPont de Nemours (DD) Stake
IFP Advisors closed its position in DuPont de Nemours, reducing its shares from 91,719 to zero as of October 16, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
IFP Advisors sold its entire stake of 91,719 shares in DuPont de Nemours, Inc. ($DD), according to a 13F filing with the SEC dated October 16, 2026.
DD
DuPont de Nemours, Inc.
Key Points
- IFP Advisors sold its entire 91,719-share position in DuPont de Nemours, valued at approximately $11.9 million at the recent price of $130.16.
- DuPont trades recently at $130.16, which is 17.6% lower than its 52-week high of $157.98, indicating a challenging price environment.
- Analysts have mixed views on DuPont, with a consensus buy rating and an average price target of $165.47, despite recent downgrades.
Get $DD trade alerts by text
We text you when insiders, Congress or big funds trade $DD. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated DuPont de Nemours, Inc. alert may contain errors. Disclosures
In a filing on October 16, 2026, IFP Advisors disclosed that it sold out of its position in DuPont de Nemours, Inc. (NYSE: DD). The firm cut its stake from 91,719 shares to zero, reflecting a 100% decrease in its investment.
What Changed in IFP Advisors' DuPont Position
IFP Advisors closed its position, selling all 91,719 shares previously held. This sale comes as part of the firm’s strategic adjustments, but the exact reasons for the exit weren't detailed in the filing.
Other Institutional Activity in DuPont
Several other institutions maintain significant stakes in DuPont. BlackRock Inc. grew its holdings by 250,339 shares, bringing its total to 10,637,868 shares valued at about $1.39 billion. Vanguard Capital Management LLC added 70,918 shares, increasing its stake to 8,935,728 shares worth around $1.17 billion. State Street Corporation also boosted its holdings by 715,117 shares, ending with 6,949,792 shares valued at about $906.6 million.
DuPont de Nemours, Inc. Stock Down 1.1%
DuPont shares are currently trading at $130.16 as of October 16, 2026. This price is below both the 50-day moving average of $133.73 and the 200-day moving average of $138.00. Additionally, the stock is down 17.6% from its 52-week high of $157.98.
Recent Earnings
DuPont reported a trailing twelve-month revenue of approximately $6.99 billion and earnings per share (EPS) of $3.72. The company is set to announce its next earnings on November 3, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
1 analysts raised price targets.
-
EPS & revenue
EPS beat estimates by 10.4%. Revenue missed estimates by 2.0%.
-
Profit surprise
EBITDA missed by 46 percent. Operating income missed by 52 percent.
-
Pre-earnings setup
Bar was high, analysts already very bullish.
-
Analyst signal
1 target raise.
-
Earnings quality
Gross margin up 3.2 points. Operating margin down 5.0 points. Positive free cash flow.
Earnings Call Summary
DuPont delivered a strong first quarter with organic sales growth of 2 percent and 20 percent adjusted earnings growth on a pro forma basis. Healthcare sales were especially strong at high single digit growth, while water was hampered by about $10 million in shipment delays from Middle East logistics disruptions. Management emphasized continued innovation, with plans to launch an AI platform for product development, and noted steady progress on their operational improvement program including Kaizen events. The company completed the Aramids divestiture and announced a $275 million accelerated share buyback, returning capital to shareholders while maintaining balance sheet strength.
Guidance DuPont raised full year sales guidance to about $7.2 billion and adjusted earnings to $2.35 to $2.40 per share. They expect about 4 percent organic growth for the year, including roughly 1 percent from pricing to cover higher raw material costs from the Middle East conflict. The company also projects strong margin expansion through the rest of the year.
Neutral report. Results and guidance were close to expectations, with limited evidence of a reset either way.
Insider Buying and Selling at DuPont de Nemours, Inc.
On June 2, 2026, Chief Executive Officer Lori Koch sold 260 shares of DuPont at an average price of $48.82, totaling about $12,741. This transaction was not part of a pre-planned trading program.
Analysts Set New Price Targets
On October 15, 2026, RBC Capital maintained its Outperform rating on DuPont with a target of $160. Earlier, JP Morgan downgraded the company to Neutral with a revised target of $145 on October 9, while both UBS and Citigroup maintained Buy ratings with targets of $172 and $162, respectively.
About DuPont
DuPont de Nemours, Inc. is a leader in providing technology and materials solutions across various sectors, including healthcare and water technologies. The company's broad reach includes operations in North America, Europe, Asia, and South America, making it a crucial player in the specialty chemicals industry.
Bottom Line
With IFP Advisors selling its entire stake, eyes will be on DuPont's next earnings report on November 3, 2026, to see how the company continues to navigate market challenges. This filing reflects positions as of the reporting period and may not represent current investor actions. Keep in mind that 13F filings are backward-looking: they show holdings as of the end of the reporting quarter and may not represent the fund's current position.
Related Filing Alerts
Source: IFP Advisors's 13F filing on $DD (Oct 16, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: IFP Advisors 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts